Cargando…

Breakthrough infections with the SARS-CoV-2 Delta variant: vaccinations halved transmission risk

OBJECTIVES: The SARS-CoV-2 Delta variant (B.1.617.2) is associated with increased infectivity. Data on breakthrough SARS-CoV-2 Delta variant infections in vaccinated individuals and transmission risk are limited. The aim of this study was to provide estimates of transmission risk in Delta variant br...

Descripción completa

Detalles Bibliográficos
Autores principales: Hsu, L., Hurraß, J., Kossow, A., Klobucnik, J., Nießen, J., Wiesmüller, G.A., Grüne, B., Joisten, C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Ltd on behalf of The Royal Society for Public Health. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8747938/
https://www.ncbi.nlm.nih.gov/pubmed/35152039
http://dx.doi.org/10.1016/j.puhe.2022.01.005
_version_ 1784630952726626304
author Hsu, L.
Hurraß, J.
Kossow, A.
Klobucnik, J.
Nießen, J.
Wiesmüller, G.A.
Grüne, B.
Joisten, C.
author_facet Hsu, L.
Hurraß, J.
Kossow, A.
Klobucnik, J.
Nießen, J.
Wiesmüller, G.A.
Grüne, B.
Joisten, C.
author_sort Hsu, L.
collection PubMed
description OBJECTIVES: The SARS-CoV-2 Delta variant (B.1.617.2) is associated with increased infectivity. Data on breakthrough SARS-CoV-2 Delta variant infections in vaccinated individuals and transmission risk are limited. The aim of this study was to provide estimates of transmission risk in Delta variant breakthrough infections. STUDY DESIGN: A matched case-control study was performed.. METHODS: To analyse onward transmission of fully vaccinated individuals infected with B.1.617.2, we compared 85 patients (vaccination group [VG]) with an age- and sex-matched unvaccinated control group (CG; n = 85). RESULTS: Transmission of B.1.617.2 was significantly reduced (halved) in the VG. The number of infected contacts to total number of contacts per infected person was 0.26 ± 0.40 in the VG vs 0.56 ± 0.45 in the CG (P = .001). Similarly, fully vaccinated contacts were less likely to be infected by fully vaccinated infected persons (IPs) than by unvaccinated IPs (20.0% vs 37.5%), although this association was not significant. CONCLUSIONS: Fully vaccinated contacts had 50% less transmissions than unvaccinated individuals. These findings must be verified in larger sample populations, and it is especially important to investigate the role of vaccination status of close contacts.
format Online
Article
Text
id pubmed-8747938
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher The Authors. Published by Elsevier Ltd on behalf of The Royal Society for Public Health.
record_format MEDLINE/PubMed
spelling pubmed-87479382022-01-11 Breakthrough infections with the SARS-CoV-2 Delta variant: vaccinations halved transmission risk Hsu, L. Hurraß, J. Kossow, A. Klobucnik, J. Nießen, J. Wiesmüller, G.A. Grüne, B. Joisten, C. Public Health Short Communication OBJECTIVES: The SARS-CoV-2 Delta variant (B.1.617.2) is associated with increased infectivity. Data on breakthrough SARS-CoV-2 Delta variant infections in vaccinated individuals and transmission risk are limited. The aim of this study was to provide estimates of transmission risk in Delta variant breakthrough infections. STUDY DESIGN: A matched case-control study was performed.. METHODS: To analyse onward transmission of fully vaccinated individuals infected with B.1.617.2, we compared 85 patients (vaccination group [VG]) with an age- and sex-matched unvaccinated control group (CG; n = 85). RESULTS: Transmission of B.1.617.2 was significantly reduced (halved) in the VG. The number of infected contacts to total number of contacts per infected person was 0.26 ± 0.40 in the VG vs 0.56 ± 0.45 in the CG (P = .001). Similarly, fully vaccinated contacts were less likely to be infected by fully vaccinated infected persons (IPs) than by unvaccinated IPs (20.0% vs 37.5%), although this association was not significant. CONCLUSIONS: Fully vaccinated contacts had 50% less transmissions than unvaccinated individuals. These findings must be verified in larger sample populations, and it is especially important to investigate the role of vaccination status of close contacts. The Authors. Published by Elsevier Ltd on behalf of The Royal Society for Public Health. 2022-03 2022-01-11 /pmc/articles/PMC8747938/ /pubmed/35152039 http://dx.doi.org/10.1016/j.puhe.2022.01.005 Text en © 2022 The Authors Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Short Communication
Hsu, L.
Hurraß, J.
Kossow, A.
Klobucnik, J.
Nießen, J.
Wiesmüller, G.A.
Grüne, B.
Joisten, C.
Breakthrough infections with the SARS-CoV-2 Delta variant: vaccinations halved transmission risk
title Breakthrough infections with the SARS-CoV-2 Delta variant: vaccinations halved transmission risk
title_full Breakthrough infections with the SARS-CoV-2 Delta variant: vaccinations halved transmission risk
title_fullStr Breakthrough infections with the SARS-CoV-2 Delta variant: vaccinations halved transmission risk
title_full_unstemmed Breakthrough infections with the SARS-CoV-2 Delta variant: vaccinations halved transmission risk
title_short Breakthrough infections with the SARS-CoV-2 Delta variant: vaccinations halved transmission risk
title_sort breakthrough infections with the sars-cov-2 delta variant: vaccinations halved transmission risk
topic Short Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8747938/
https://www.ncbi.nlm.nih.gov/pubmed/35152039
http://dx.doi.org/10.1016/j.puhe.2022.01.005
work_keys_str_mv AT hsul breakthroughinfectionswiththesarscov2deltavariantvaccinationshalvedtransmissionrisk
AT hurraßj breakthroughinfectionswiththesarscov2deltavariantvaccinationshalvedtransmissionrisk
AT kossowa breakthroughinfectionswiththesarscov2deltavariantvaccinationshalvedtransmissionrisk
AT klobucnikj breakthroughinfectionswiththesarscov2deltavariantvaccinationshalvedtransmissionrisk
AT nießenj breakthroughinfectionswiththesarscov2deltavariantvaccinationshalvedtransmissionrisk
AT wiesmullerga breakthroughinfectionswiththesarscov2deltavariantvaccinationshalvedtransmissionrisk
AT gruneb breakthroughinfectionswiththesarscov2deltavariantvaccinationshalvedtransmissionrisk
AT joistenc breakthroughinfectionswiththesarscov2deltavariantvaccinationshalvedtransmissionrisk